On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 49, Issue 98, Pages 11533
Publisher
Royal Society of Chemistry (RSC)
Online
2013-10-18
DOI
10.1039/c3cc46239k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
- (2013) Jessica M. Hearn et al. ACS Chemical Biology
- Anticancer cyclometalated complexes of platinum group metals and gold
- (2013) Natalia Cutillas et al. COORDINATION CHEMISTRY REVIEWS
- Bioactive iridium and rhodium complexes as therapeutic agents
- (2013) Chung-Hang Leung et al. COORDINATION CHEMISTRY REVIEWS
- Cancer Cell Cytotoxicity of Cyclometalated Compounds Obtained with Osmium(II) Complexes
- (2013) Bastien Boff et al. INORGANIC CHEMISTRY
- Novel Bis-C,N-Cyclometalated Iridium(III) Thiosemicarbazide Antitumor Complexes: Interactions with Human Serum Albumin and DNA, and Inhibition of Cathepsin B
- (2013) José Ruiz et al. INORGANIC CHEMISTRY
- The Contrasting Activity of Iodido versus Chlorido Ruthenium and Osmium Arene Azo- and Imino-pyridine Anticancer Complexes: Control of Cell Selectivity, Cross-Resistance, p53 Dependence, and Apoptosis Pathway
- (2013) Isolda Romero-Canelón et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
- (2012) Wukun Liu et al. CHEMICAL SOCIETY REVIEWS
- Novel C,N-chelate rhodium(iii) and iridium(iii) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA
- (2012) José Ruiz et al. DALTON TRANSACTIONS
- N-Heterocyclic carbene metal complexes in medicinal chemistry
- (2012) Luciano Oehninger et al. DALTON TRANSACTIONS
- Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies
- (2012) Orsolya Dömötör et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
- (2012) Christian G. Hartinger et al. ORGANOMETALLICS
- Osmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agents
- (2012) Wen-Xiu Ni et al. Chemical Science
- Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold
- (2010) Eric D. Jones et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multidisciplinary Synthetic Approach for Rapid Combinatorial Library Synthesis of Triaza-Fluorenes
- (2010) Ya-Shan Hsiao et al. JOURNAL OF COMBINATORIAL CHEMISTRY
- Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol
- (2010) Hung Yi Kristal Kaan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Organometallic Anticancer Compounds
- (2010) Gilles Gasser et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel ruthenium(ii) arene based intercalator with potent anticancer activity
- (2009) José Ruiz et al. DALTON TRANSACTIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started